Faruqi & Faruqi Encourages Lufax Investors to Reach Out
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 6 days ago
0mins
Should l Buy LU?
Source: PRnewswire
- Legal Investigation: Faruqi & Faruqi LLP is investigating potential claims against Lufax Holding Ltd. due to possible false statements made during securities transactions from April 7, 2023, to January 26, 2025, which may have harmed investors' rights.
- Financial Misstatements: The lawsuit alleges that Lufax lacked adequate internal controls and that certain financial results were materially misstated, resulting in misleading statements from executives that lacked a reasonable basis, ultimately causing investor losses.
- Stock Price Impact: On January 27, 2025, Lufax disclosed a proposal to remove its auditors, leading to a $0.40 drop in its American Depositary Shares, a 13.8% decline to close at $2.49, reflecting market concerns over corporate governance.
- Investor Rights Reminder: Faruqi & Faruqi reminds investors that May 20, 2026, is the deadline to apply as lead plaintiff in the federal securities class action, encouraging affected investors to reach out to discuss their legal options.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy LU?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on LU
About LU
LUFAX HOLDING LTD is a holding company mainly engaged in providing financial services for small and micro enterprises. The Company's core retail credit enablement business includes bank-funded loans, trust-funded loans and consumer finance loans. The Company is also engaged in wealth management and providing access to financial products and services. The Company conducts the business through its subsidiaries.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Faruqi & Faruqi Encourages Lufax Investors to Reach Out
- Legal Investigation: Faruq & Faruqi LLP is investigating potential claims against Lufax Holding Ltd. related to securities purchased between April 7, 2023, and January 26, 2025, indicating possible legal risks that could undermine investor confidence in the company.
- Investor Contact Information: Securities Litigation Partner Josh Wilson encourages affected investors to reach out directly via phone at 877-247-4292 or 212-983-9330 (Ext. 1310) to discuss their legal rights, demonstrating a commitment to protecting investor interests.
- Class Action Deadline: The firm reminds investors that the deadline to seek the role of lead plaintiff in the federal securities class action against Lufax is May 20, 2026, emphasizing the importance of timely action to safeguard their legal rights.
- Potential Market Impact: The ongoing legal investigation and class action could negatively affect Lufax's stock price, prompting investors to monitor developments closely to assess their investment risks and potential losses.
See More
Lufax Shareholder Files Securities Class Action Lawsuit
- Class Action Initiated: A shareholder has filed a securities class action lawsuit against Lufax Holding Ltd for misrepresentations regarding the company's internal controls, which allegedly led to materially misstated financial results, impacting investor interests during the period from April 7, 2023, to January 26, 2025.
- Legal Representation Details: Investors wishing to participate in the lawsuit or serve as lead plaintiff must file necessary documents by May 20, 2026, with all legal representation provided on a contingency fee basis, meaning shareholders incur no fees or expenses.
- Lawsuit Context: The lawsuit highlights significant concerns regarding Lufax's financial reporting due to internal control issues, suggesting potential risks in the company's governance structure that may have resulted in investor losses during the specified period.
- Law Firm Credentials: Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has extensive experience in litigating hundreds of class actions, underscoring its strong reputation and capability in the legal field.
See More
Reminder of Lufax Securities Class Action
- Class Action Notice: Rosen Law Firm reminds investors who purchased Lufax securities between April 7, 2023, and January 26, 2025, to apply as lead plaintiffs by May 20, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Lufax failed to disclose inadequate internal controls and materially misstated financial results during the class period, resulting in investor losses when the true information was revealed, thereby damaging the company's reputation and shareholder confidence.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, ranked No. 1 by ISS Securities Class Action Services in 2017, highlighting its expertise and success in this field.
- Investor Action Advice: Investors can visit Rosen Law Firm's website or call the toll-free number for more information, ensuring they select qualified legal counsel to effectively represent them in the lawsuit and avoid inexperienced intermediary firms.
See More
Lufax Faces Class Action Lawsuit for Investor Rights
- Class Action Initiated: Bragar Eagel & Squire has filed a class action lawsuit against Lufax in the Central District of California, representing investors who purchased Lufax securities between April 7, 2023, and January 26, 2025, indicating strong investor dissatisfaction with the company's financial transparency.
- Allegation Details Revealed: The lawsuit alleges that Lufax failed to disclose inadequate internal controls and materially misstated financial results during the class period, leading to investor losses when the true information was revealed, highlighting significant flaws in the company's governance structure.
- Investor Rights Protection: Investors must apply by May 20, 2026, to be appointed as lead plaintiffs, reflecting concerns over corporate governance and financial reporting that could impact Lufax's market reputation and stock price.
- Legal Consultation Channels: Bragar Eagel & Squire offers free consultations, encouraging affected investors to contact attorneys directly, demonstrating the law firm's commitment to protecting investor rights.
See More
Lufax Faces Class Action Lawsuit, Shares Plunge 14%
- Class Action Initiated: A class action lawsuit has been filed against Lufax for securities transactions between April 7, 2023, and January 26, 2025, representing investors seeking to recover losses, highlighting serious concerns over the company's financial transparency.
- Auditor Dismissal: On January 27, 2025, Lufax announced the dismissal of PricewaterhouseCoopers as its auditor due to concerns over undisclosed related-party transactions, triggering a nearly 14% drop in share price that day, reflecting a crisis of trust in corporate governance.
- Financial Reporting Allegations: The lawsuit alleges that Lufax lacked adequate internal controls and that its financial results were materially misstated, severely undermining investor confidence in the company's financial health and potentially impacting its future financing capabilities.
- Investigation and Whistleblower Mechanism: Hagens Berman is investigating whether Lufax intentionally violated accounting rules and encourages whistleblowers to come forward, indicating strong scrutiny on the company's transparency and compliance, which could lead to broader legal repercussions.
See More
Class Action Lawsuits Filed for Multiple Companies
- Lufax Shareholder Lawsuit: Shareholders of Lufax Holding Ltd. have filed a class action due to the company's failure to disclose inadequate internal controls and misstated financial results during the period from April 7, 2023, to January 26, 2025, with a lead plaintiff deadline of May 20, 2026.
- Atara Biotherapeutics Lawsuit: Atara Biotherapeutics, Inc. shareholders initiated a lawsuit for the period from May 20, 2024, to January 9, 2026, alleging undisclosed manufacturing issues and clinical trial risks that jeopardized FDA approval prospects, with a lead plaintiff deadline of May 22, 2026.
- Coty Shareholder Class Action: Coty Inc. shareholders have filed a class action due to the company's failure to disclose underperformance in its Consumer Beauty segment and slowing market growth from November 5, 2025, to February 4, 2026, with a lead plaintiff deadline of May 22, 2026.
- Legal Consultation Information: The Law Offices of Frank R. Cruz remind investors who suffered losses during these periods to contact them for legal advice to protect their rights and interests.
See More
Faruqi & Faruqi Encourages Lufax Investors to Reach Out
- Legal Investigation: Faruq & Faruqi LLP is investigating potential claims against Lufax Holding Ltd. related to securities purchased between April 7, 2023, and January 26, 2025, indicating possible legal risks that could undermine investor confidence in the company.
- Investor Contact Information: Securities Litigation Partner Josh Wilson encourages affected investors to reach out directly via phone at 877-247-4292 or 212-983-9330 (Ext. 1310) to discuss their legal rights, demonstrating a commitment to protecting investor interests.
- Class Action Deadline: The firm reminds investors that the deadline to seek the role of lead plaintiff in the federal securities class action against Lufax is May 20, 2026, emphasizing the importance of timely action to safeguard their legal rights.
- Potential Market Impact: The ongoing legal investigation and class action could negatively affect Lufax's stock price, prompting investors to monitor developments closely to assess their investment risks and potential losses.
See More
Lufax Shareholder Files Securities Class Action Lawsuit
- Class Action Initiated: A shareholder has filed a securities class action lawsuit against Lufax Holding Ltd for misrepresentations regarding the company's internal controls, which allegedly led to materially misstated financial results, impacting investor interests during the period from April 7, 2023, to January 26, 2025.
- Legal Representation Details: Investors wishing to participate in the lawsuit or serve as lead plaintiff must file necessary documents by May 20, 2026, with all legal representation provided on a contingency fee basis, meaning shareholders incur no fees or expenses.
- Lawsuit Context: The lawsuit highlights significant concerns regarding Lufax's financial reporting due to internal control issues, suggesting potential risks in the company's governance structure that may have resulted in investor losses during the specified period.
- Law Firm Credentials: Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has extensive experience in litigating hundreds of class actions, underscoring its strong reputation and capability in the legal field.
See More
Reminder of Lufax Securities Class Action
- Class Action Notice: Rosen Law Firm reminds investors who purchased Lufax securities between April 7, 2023, and January 26, 2025, to apply as lead plaintiffs by May 20, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Lufax failed to disclose inadequate internal controls and materially misstated financial results during the class period, resulting in investor losses when the true information was revealed, thereby damaging the company's reputation and shareholder confidence.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, ranked No. 1 by ISS Securities Class Action Services in 2017, highlighting its expertise and success in this field.
- Investor Action Advice: Investors can visit Rosen Law Firm's website or call the toll-free number for more information, ensuring they select qualified legal counsel to effectively represent them in the lawsuit and avoid inexperienced intermediary firms.
See More
Lufax Faces Class Action Lawsuit for Investor Rights
- Class Action Initiated: Bragar Eagel & Squire has filed a class action lawsuit against Lufax in the Central District of California, representing investors who purchased Lufax securities between April 7, 2023, and January 26, 2025, indicating strong investor dissatisfaction with the company's financial transparency.
- Allegation Details Revealed: The lawsuit alleges that Lufax failed to disclose inadequate internal controls and materially misstated financial results during the class period, leading to investor losses when the true information was revealed, highlighting significant flaws in the company's governance structure.
- Investor Rights Protection: Investors must apply by May 20, 2026, to be appointed as lead plaintiffs, reflecting concerns over corporate governance and financial reporting that could impact Lufax's market reputation and stock price.
- Legal Consultation Channels: Bragar Eagel & Squire offers free consultations, encouraging affected investors to contact attorneys directly, demonstrating the law firm's commitment to protecting investor rights.
See More
Lufax Faces Class Action Lawsuit, Shares Plunge 14%
- Class Action Initiated: A class action lawsuit has been filed against Lufax for securities transactions between April 7, 2023, and January 26, 2025, representing investors seeking to recover losses, highlighting serious concerns over the company's financial transparency.
- Auditor Dismissal: On January 27, 2025, Lufax announced the dismissal of PricewaterhouseCoopers as its auditor due to concerns over undisclosed related-party transactions, triggering a nearly 14% drop in share price that day, reflecting a crisis of trust in corporate governance.
- Financial Reporting Allegations: The lawsuit alleges that Lufax lacked adequate internal controls and that its financial results were materially misstated, severely undermining investor confidence in the company's financial health and potentially impacting its future financing capabilities.
- Investigation and Whistleblower Mechanism: Hagens Berman is investigating whether Lufax intentionally violated accounting rules and encourages whistleblowers to come forward, indicating strong scrutiny on the company's transparency and compliance, which could lead to broader legal repercussions.
See More
Class Action Lawsuits Filed for Multiple Companies
- Lufax Shareholder Lawsuit: Shareholders of Lufax Holding Ltd. have filed a class action due to the company's failure to disclose inadequate internal controls and misstated financial results during the period from April 7, 2023, to January 26, 2025, with a lead plaintiff deadline of May 20, 2026.
- Atara Biotherapeutics Lawsuit: Atara Biotherapeutics, Inc. shareholders initiated a lawsuit for the period from May 20, 2024, to January 9, 2026, alleging undisclosed manufacturing issues and clinical trial risks that jeopardized FDA approval prospects, with a lead plaintiff deadline of May 22, 2026.
- Coty Shareholder Class Action: Coty Inc. shareholders have filed a class action due to the company's failure to disclose underperformance in its Consumer Beauty segment and slowing market growth from November 5, 2025, to February 4, 2026, with a lead plaintiff deadline of May 22, 2026.
- Legal Consultation Information: The Law Offices of Frank R. Cruz remind investors who suffered losses during these periods to contact them for legal advice to protect their rights and interests.
See More
